Related Experiment Video

Updated: Jul 29, 2026

Making MR Imaging Child's Play - Pediatric Neuroimaging Protocol, Guidelines and Procedure
15:18

Making MR Imaging Child's Play - Pediatric Neuroimaging Protocol, Guidelines and Procedure

Published on: July 30, 2009

Clinical trials in children: problems and pitfalls

R E Kauffman1

  • 1Children's Mercy Hospital and University of Missouri-Kansas City, 64108, USA. rkauffman@cmh.edu

Paediatric Drugs
|December 29, 2000
PubMed

Insights

New initiatives are boosting pediatric clinical trials, but ethical considerations and age-appropriate research designs are crucial. Ensuring children benefit equally from medical advances requires careful planning and ethical oversight in pediatric drug development.

Area of Science:

  • Pediatric Pharmacology
  • Clinical Trial Design
  • Regulatory Science

Background:

  • Recent US legislative and regulatory actions have significantly incentivized the development of new drugs for pediatric populations.
  • There is a growing global emphasis on pediatric pharmaceutical development, evidenced by international guidelines like those from the International Conference on Harmonisation.

Purpose of the Study:

  • To examine the impact of recent initiatives on pediatric clinical trials.
  • To highlight the ethical considerations and methodological adaptations necessary for pediatric research.
  • To advocate for the successful and ethical execution of clinical studies for the benefit of children.

Main Methods:

  • Analysis of trends in pediatric clinical trial initiation and growth.
  • Review of regulatory incentives and international guidelines impacting pediatric drug development.
  • Discussion of ethical imperatives and adaptive trial design principles for pediatric populations.

Main Results:

  • A notable increase in the number of pediatric clinical trials conducted in the US.
  • Growing international interest and harmonization efforts in pediatric pharmaceutical research.
  • Recognition of challenges faced by industry, regulators, and investigators in meeting increased demands.

Conclusions:

  • Ethical issues unique to children must be prioritized in the evolving landscape of pediatric clinical research.
  • The adult research model is not directly transferable to pediatric studies; age-appropriate protocols are essential.
  • Continued successful and ethical clinical studies in children are vital to ensure they benefit from therapeutic advancements.

More Related Videos

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)07:01

A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)

Published on: February 7, 2025

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Blinding01:11

Blinding

Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...